Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart Failure

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation

• Publication date

  2005-05-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000165119.62099.14PMID 15883214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha1-AR-mediated activation of NKCC in rat cardiomyocytes involves ERK-dependent phosphorylation of the cotransporter.

  2004cited by this paper
• Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction.

  2004cited by this paper
• Leukaemia inhibitory factor alters expression of genes involved in rat cardiomyocyte energy metabolism.

  2004cited by this paper
• Regulation of osteoclast protease expression by RANKL.

  2003cited by this paper
• Immunomodulating therapy: new treatment modality in congestive heart failure.

  2003cited by this paper
• Increased osteoprotegerin serum levels in men with coronary artery disease.

  2003cited by this paper
• Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure.

  2002cited by this paper
• Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction.

  2002cited by this paper
• Matrix metalloproteinases: regulation and dysregulation in the failing heart.

  2002cited by this paper
• Inflammatory mediators and the failing heart: past, present, and the foreseeable future.

  2002cited by this paper
• Serum Osteoprotegerin Levels Are Associated With the Presence and Severity of Coronary Artery Disease

  2002cited by this paper
• Immunomodulating Therapy With Intravenous Immunoglobulin in Patients With Chronic Heart Failure

  2001cited by this paper
• Serum measurement of osteoprotegerin--clinical relevance and potential applications.

  2001cited by this paper
• Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).

  2001cited by this paper
• Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.

  2001cited by this paper
• Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis.

  2001cited by this paper
• Lithocholic acid and sulphated lithocholic acid differ in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line CaCo-2.

  2000cited by this paper
• The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

  2000cited by this paper
• 8-Iso-Prostaglandin F2α Reduces Trophoblast Invasion and Matrix Metalloproteinase Activity

  2000cited by this paper
• 8-Iso-prostaglandin f(2alpha) reduces trophoblast invasion and matrix metalloproteinase activity.

  2000cited by this paper
• Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats.

  2000cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency.

  1999cited by this paper
• Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure.

  1999cited by this paper
• Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.

  1999cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Effect of a coffee lipid (cafestol) on cholesterol metabolism in human skin fibroblasts.

  1998cited by this paper
• Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats.

  1997cited by this paper
• Transient, isopeptide-specific induction of myocardial endothelin-1 mRNA in congestive heart failure in rats.

  1997cited by this paper
• Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha.

  1997cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α

  1997cited by this paper

• Integrative Mechanisms of Osteoprotegerin in Cardiovascular Pathophysiology

  2026cites this paper
• Cardiovascular adverse events associated with denosumab versus zoledronic acid in patients with breast cancer: a propensity score overlap weighted analysis

  2025cites this paper
• The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring.

  2025cites this paper
• Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of CRIC and PACE studies

  2025cites this paper
• Heart Failure and Osteoporosis: Shared Challenges in the Aging Population

  2025cites this paper
• Exploring the Clinical Utility of Osteoprotegerin in Heart Failure—A Systematic Review and Meta-Analysis

  2025cites this paper
• A variant form of receptor activator of nuclear factor-κB functions as an osteoprotegerin mimic in bone and cardiac development

  2025cites this paper
• Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β Ligand and Glycoprotein Non-Metastatic Melanoma Protein B) in People with Type 2 Diabetes

  2024cites this paper
• Mechanism of Wenshen Xuanbi Decoction in the treatment of osteoarthritis based on network pharmacology and experimental verification

  2024cites this paper
• The Prognostic, Diagnostic, and Therapeutic Potential of TRAIL Signalling in Cardiovascular Diseases

  2023cites this paper
• Tumor Necrosis Factor Family Members and Myocardial Ischemia-Reperfusion Injury: State of the Art and Therapeutic Implications

  2023cites this paper
• Osteoprotegerin is associated with subclinical left ventricular systolic dysfunction in non-dipper hypertensive patients: a 2D speckle tracking echocardiographic study

  2023cites this paper
• OPG/RANK/RANKL axis relation to cardiac iron-overload in children with transfusion-dependent thalassemia

  2023cites this paper
• Secukinumab and Black Garlic Downregulate OPG/RANK/RANKL Axis and Devitalize Myocardial Interstitial Fibrosis Induced by Sunitinib in Experimental Rats

  2023cites this paper
• Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease

  2023cites this paper
• TRAIL and its receptors in cardiac diseases

  2023cites this paper
• RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy

  2023influential citation
• Decreased serum MMP-9 levels in patients with nontraumatic osteonecrosis of the femoral head

  2023cites this paper
• Inverse Regulation of Serum Osteoprotegerin and B-Type Natriuretic Peptide Concentrations by Free Fatty Acids Elevation in Young Healthy Humans

  2022cites this paper
• Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children

  2022cites this paper
• The Roles of RANK/RANKL/OPG in Cardiac, Skeletal, and Smooth Muscles in Health and Disease

  2022cites this paper
• Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

  2022cites this paper
• Identification of a novel TNFRSF11A gene variant in a rare case of familial osteopetrosis autosomal recessive type 7

  2022cites this paper
• Osteoprotegerin and Ischemic Stroke Prognosis: A Prospective Multicenter Study and Mendelian Randomization Analysis

  2022cites this paper
• Tomatidine Suppresses the Destructive Behaviors of Fibroblast-Like Synoviocytes and Ameliorates Type II Collagen-Induced Arthritis in Rats

  2021cites this paper
• Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes

  2021cites this paper
• Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases

  2021cites this paper
• The role of osteoprotegerin (OPG) in fibrosis: Its potential as a biomarker and/or biological target for the treatment of fibrotic diseases.

  2021cites this paper
• Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients

  2021cites this paper
• The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis

  2021cites this paper
• Cardiac Adipose Tissue Contributes to Cardiac Repair: a Review

  2021cites this paper
• A Dual Role for Death Receptor 5 in Regulating Cardiac Fibroblast Function

  2021cites this paper
• Diagnostic biomarkers of dilated cardiomyopathy.

  2021cites this paper
• OSTEOPROTEGERIN INJECTION INDUCES MORPHOLOGICAL AND FUNCTIONAL ALTERATIONS IN MOUSE PANCREATIC ISLETS

  2020cites this paper
• Role of Innate Immunity in Heart Failure

  2020cites this paper
• Associations of Bone Turnover Markers with Cognitive Function in Patients Undergoing Hemodialysis

  2020cites this paper
• Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure

  2020influential citation
• Clinical Risk Factors and Prognostic Impact of Osteoporosis in Patients With Chronic Heart Failure.

  2020cites this paper
• Serum osteoprotegerin level is independently related to subclinical left atrial mechanical function in patients with hypertension and diabetes

  2020cites this paper
• Association of a single nucleotide polymorphism of RANK gene with blood pressure in Spanish women

  2020cites this paper
• The Role of Osteoprotegerin and Its Ligands in Vascular Function

  2019cites this paper
• Biomarkers Determining Prognosis of Atrial Fibrillation Ablation.

  2019cites this paper
• Biomarkers Associated with Atrial Fibrosis and Remodeling.

  2019cites this paper
• Biomarkers in diagnosing and treatment of acute heart failure.

  2019cites this paper
• Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile paget disease.

  2019cites this paper
• Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus

  2019cites this paper
• The Role of Osteoprotegerin in Vascular Calcification and Bone Metabolism: The Basis for Developing New Therapeutics

  2019cites this paper
• Cytokines in heart failure.

  2019cites this paper
• Osteoprotegerin and osteopontin levels, but not gene polymorphisms, predict mortality in cardiovascular diseases.

  2019cites this paper
• TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?

  2019cites this paper
• Kidney osteoclast factors and matrix metalloproteinase expression in a mice model of diet-induced obesity and diabetes

  2019cites this paper
• Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction

  2018cites this paper
• Functional promoter −1816C>G variant of RANKL predicts risk and prognosis of lone atrial fibrillation

  2018cites this paper
• The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox

  2018influential citation
• The role of pericardial adipose tissue in the heart of obese minipigs

  2018cites this paper
• FAM210A is a novel determinant of bone and muscle structure and strength

  2018cites this paper
• Osteoprotegerin and Cardiovascular Events in High‐Risk Populations: Meta‐Analysis of 19 Prospective Studies Involving 27 450 Participants

  2018cites this paper
• Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial

  2018cites this paper
• Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus.

  2018cites this paper
• Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis

  2018cites this paper
• The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases

  2017cites this paper
• Serum Osteoprotegerin in Patients with Calcified Aortic Valve Stenosis in Relation to Heart Failure.

  2017cites this paper
• Association of RANK/RANKL/OPG gene polymorphisms with risk of peripheral arterial disease (PAD) and critical limb ischemia in the general Italian population

  2017cites this paper
• Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease

  2017cites this paper
• Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients

  2017cites this paper
• [Osteoprotegerin is a new marker of cardiovascular diseases].

  2017cites this paper
• Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study

  2017cites this paper
• Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness

  2017cites this paper
• Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study

  2017cites this paper
• Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population

  2017cites this paper
• Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function

  2017cites this paper
• Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats

  2016influential citation
• Взаимосвязь патогенеза атеросклероза и остеопороза

  2016cites this paper
• Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice

  2016cites this paper
• Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

  2016cites this paper
• MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure

  2016influential citation
• Fibroblast growth factor 23 serum level in type 2 diabetic italian subjects with peripheral arterial disease and critical limb ischemia.

  2016cites this paper
• 4048-4054-FGF23 serum level in type 2 diabetic italian subjects with PAD and critical limb ischemia

  2016cites this paper
• Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System

  2016cites this paper
• Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study

  2016cites this paper
• Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene.

  2016cites this paper
• Midkine Deteriorates Cardiac Remodeling via Epidermal Growth Factor Receptor Signaling in Chronic Kidney Disease

  2016cites this paper
• Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study

  2016cites this paper
• Innate immunity and the failing heart: the cytokine hypothesis revisited.

  2015cites this paper
• Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes

  2015cites this paper
• Bone-Related Proteins as Markers in Vascular Remodeling

  2015cites this paper
• DATA SUPPLEMENT FOR: INNATE IMMUNITY AND THE FAILING HEART: THE CYTOKINE HYPOTHESIS REVISITED TOLL-LIKE RECEPTOR SIGNALING PATHWAYS

  2015cites this paper
• Vascular Remodelling and Cardiovascular Outcomes: Predictive Role of Matricellular Proteins

  2015cites this paper
• Prognostic Value of Osteoprotegerin in Acute Heart Failure.

  2015cites this paper
• Clinical Research Prognostic Value of Osteoprotegerin in Acute Heart Failure

  2015cites this paper
• Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging

  2015cites this paper
• Consolidated and emerging inflammatory markers in coronary artery disease.

  2015cites this paper
• Sleep-disordered breathing is associated with depletion of circulating endothelial progenitor cells and elevation in pulmonary arterial pressure in patients with decompensated systolic heart failure

  2015cites this paper
• Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis

  2015cites this paper
• Osteoprotegerin is associated with depletion of circulating endothelial progenitor cells and elevation in pulmonary arterial pressure in patients with systolic heart failure

  2015cites this paper
• Relationship Between Serum RANKL/Osteoprotegerin Complex and Endothelial Progenitor Cells in Ischemic Chronic Heart Failure

  2014cites this paper
• Sharpin is a key regulator of skeletal homeostasis in a TNF-dependent manner.

  2014cites this paper
• Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6

  2014cites this paper
• Preoperative Serum Receptor Activator of Nuclear Factor-κB Ligand/Osteoprotegerin Predict Stabilization of Spontaneously Restored Sinus Rhythm in Persistent Atrial Fibrillation Patients after Mitral Valve Surgery

  2014cites this paper
• Low bone mineral density predicts incident heart failure in men and women: the EPIC (European Prospective Investigation into Cancer and Nutrition)-Norfolk prospective study.

  2014cites this paper